Skip to main content

Advertisement

Fig. 5 | Journal of Translational Medicine

Fig. 5

From: Mobilization of hematopoietic stem cells with the novel CXCR4 antagonist POL6326 (balixafortide) in healthy volunteers—results of a dose escalation trial

Fig. 5

Mobilization of plasmacytoid dendritic cell (pDC) progenitors. Displayed are representative flow cytograms of putative pro-pDCs (defined as CD34dimCD45dimCD45RA+CD123high) detected in G-CSF (top) or balixafortide (bottom) mobilized blood. Mean (±SEM) percentages of pDC progenitors within the HSPC fraction CD34+CD45dim detected in all G-CSF and balixafortide (1st treatment, constant infusion rate, 2 h, Table 1) mobilized specimen (n = 21) are shown in the bottom

Back to article page